Carton (Carton)
Lacosamide Injection
Product Images NDC 43598-087
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 43598-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Figure1)
This is a description of a study evaluating the effect of Lacosamide on pain reduction. It indicates a statistically significant difference in pain reduction when compared to a placebo. The study seems to involve an analysis related to the use of Lacosamide for pain management.*
Figure2 (Figure2)
This is a comparison chart depicting responder rates (equal to or greater), improvement, and worsening for different dosages of lacosamide and a placebo. The data includes the number of patients in each group and the percentage of patients for each category. The different dosages of lacosamide evaluated are 200mg/day, 400mg/day, and 600mg/day, with varying numbers of patients in each group.*
Figure3 (Figure3)
This text provides information related to the proportion of patents, risk, p-value, hazard ratio, confidence interval, and time in days. The hazard ratio indicates a risk reduction of 45.2%, with a 95% confidence interval between 0.381 and 0.788. The p-value is 0.0001. Time (Days) is also mentioned.*
Structure (Structure)
Vial (Vial)
This is a description of a medication labeled as Lacosamide Injection, USP, with a concentration of 200 mg/20 mL. It is intended for intravenous use only and comes in a 20mL single-dose vial. The usual dosage information can be found in the package insert. Unused portions should be discarded, and the medication should be stored at a temperature between 20°C to 25°C. The medication is set to expire in October 2023 and is distributed by Dr. Reddy's Laboratories Inc. Made in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
